Abstract

Salmonella enterica subsp. enterica serovar Stanley (S. Stanley) is a pathogen that contaminates food, and is related to Salmonella outbreaks in a variety of hosts such as humans and farm animals through products like dairy items and vegetables. Despite the fact that several vaccines of Salmonella strains had been constructed, none of them were developed according to serovar Stanley up to this day. This study presents results of genome sequencing and analysis on our S. Stanley UPM 517 strain taken from fecal swabs of 21-day-old healthy commercial chickens in Perak, Malaysia and used Salmonella enterica subsp. enterica serovar Typhimurium LT2 (S. Typhimurium LT2) as a reference to be compared with. First, sequencing and assembling of the Salmonella Stanley UPM 517 genome into a contiguous form were done. The work was then continued with scaffolding and gap filling. Annotation and alignment of the draft genome was performed with S. Typhimurium LT2. The other elements of virulence estimated in this study included Salmonella pathogenicity islands, resistance genes, prophages, virulence factors, plasmid regions, restriction-modification sites and the CRISPR-Cas system. The S. Stanley UPM 517 draft genome had a length of 4,736,817 bp with 4,730 coding sequence and 58 RNAs. It was discovered via genomic analysis on this strain that there were antimicrobial resistance properties toward a wide variety of antibiotics. Tcf and ste, the two fimbrial virulence clusters related with human and broiler intestinal colonizations which were not found in S. Typhimurium LT2, were atypically discovered in the S. Stanley UPM 517 genome. These clusters are involved in the intestinal colonization of human and broilers, respectively. There were seven Salmonella pathogenicity islands (SPIs) within the draft genome, which contained the virulence factors associated with Salmonella infection (except SPI-14). Five intact prophage regions, mostly comprising of the protein encoding Gifsy-1, Fels-1, RE-2010 and SEN34 prophages, were also encoded in the draft genome. Also identified were Type I–III restriction-modification sites and the CRISPR-Cas system of the Type I–E subtype. As this strain exhibited resistance toward numerous antibiotics, we distinguished several genes that had the potential for removal in the construction of a possible vaccine candidate to restrain and lessen the pervasiveness of salmonellosis and to function as an alternative to antibiotics.

Highlights

  • According to Crump et al (2015) and Williamson et al (2017), Salmonella enterica serovar Stanley

  • SPIFinder, which can be obtained from the Center for Genomic Epidemiology website, was used to identify Salmonella pathogenicity islands (SPIs) with 95% and 60% of identity threshold and minimum length, respectively

  • We have singled out several genes that we found to be suitable for removal in the development of potential vaccine candidates for controlling and reducing salmonella pervasiveness as well as to become a substitute to antibiotics

Read more

Summary

Introduction

According to Crump et al (2015) and Williamson et al (2017), Salmonella enterica serovar Stanley Characterized as O:4 (B) serogroup with 1,4,[5],12,[27]:d:1,2 antigenic formula (Grimont & Weill, 2007), it is able to start salmonellosis outbreaks in humans by contaminating food-producing animals as well as eggs, dairy products, fruits and vegetables (Dahshan et al, 2010; Eng et al, 2015). Stanley was positioned the fifth most regular serovar which caused Salmonellosis in 3,657 cases. Stanley as being the 36th serotype that was related with human salmonellosis out of 10,378 serotyped Salmonella. During the period of 2002–2007, Thailand recorded 11% cases of salmonellosis in humans due to this serovar (Hendriksen et al, 2009, 2012). More recently similar cases were reported in King County, Washington state, USA, infecting nine people in 2017 (King County, 2017)

Methods
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.